Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000286522 | SCV000329551 | pathogenic | not provided | 2016-08-10 | criteria provided, single submitter | clinical testing | The C81F variant has been published previosuly in association with autosomal dominant periodic fever (McDermott et al., 1999). The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. C81F is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the TNFR-Cys1 repeat region that is conserved across species; this position forms a critical disulfide bond with the C62 residue (Aksentijevich et al., 2001). In silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, multiple functional studies have shown that C81F disrupts normal TNFRSF1A function and localization (Todd et al., 2004; Lobito et al., 2006; Rebelo et al., 2009). Missense variants in the same residue (C81G/R/Y) and in nearby residues (T79M/K, C84R/Y/S, E85D) have been reported in the Human Gene Mutation Database in association with periodic fever (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, we consider this variant to be pathogenic. |
| OMIM | RCV000013131 | SCV000033378 | pathogenic | TNF receptor-associated periodic fever syndrome (TRAPS) | 1999-04-02 | no assertion criteria provided | literature only | |
| Unité médicale des maladies autoinflammatoires, |
RCV000013131 | SCV000116034 | not provided | TNF receptor-associated periodic fever syndrome (TRAPS) | no assertion provided | not provided |